KAKKIS EMIL D - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 3, 2024, KAKKIS EMIL D's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Director,Officer (President & CEO), and currently has 2,223,985 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RARE insiders.
Data Source: SEC.
KAKKIS EMIL D - Insider Non-Derivative Transactions of RARE Common Stock
KAKKIS EMIL D - Insider Non-Derivative Transactions at RARE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 4, 2024 | Sell -- (Common Stock) | 20000 | 55.85 | 2223985 |
| Aug 7, 2024 | Sell -- (Common Stock) | 20000 | 50.17 | 2243985 |
| Mar 2, 2024 | F -- (Common Stock) | 17417 | 53.69 | 560781 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 3132 | 0 | 563913 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 38428 | 0 | 578198 |
| Feb 8, 2024 | Sell -- (Common Stock) | 30000 | 45 | 539770 |
| Dec 30, 2023 | Sell -- (Common Stock) | 30000 | 47.87 | 569770 |
| Oct 20, 2023 | Sell -- (Common Stock) | 47853 | 33.52 | 599743 |
| Oct 20, 2023 | M -- (Common Stock) | 47853 | 6.86 | 647029 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 8716 | 0 | 569406 |
| Mar 2, 2023 | F -- (Common Stock) | 16140 | 45.65 | 599176 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 46200 | 0 | 615606 |
| Dec 31, 2022 | Sell -- (Common Stock) | 19582 | 45.57 | 541108 |